0

Quinidine Sulfate Market by Disease Type and Geography - Forecast and Analysis 2022-2026

  • Published: Aug 2022
  • Pages: 117
  • SKU: IRTNTR73837
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The quinidine sulfate market share is expected to increase by USD 427.29 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 6.7%.

This quinidine sulfate market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers quinidine sulfate market segmentation by disease type (malaria and arrhythmias) and geography (North America, Europe, Asia, and Rest of World (ROW)). The quinidine sulfate market report also offers information on several market vendors, including Bennet Pharmaceuticals Ltd., Buchler GmbH, Cipla Ltd., Ipca Laboratories Ltd., Lark Laboratories India Ltd., Merck and Co. Inc., Merck KGaA, PRISM INDUSTRIES LTD., Teva Pharmaceutical Industries Ltd., VIVAN Life Sciences Pvt. Ltd., Biophore India Pharmaceuticals Pvt. Ltd., Inga Laboratories P. Ltd., Koninklijke DSM NV, PMC Group Inc., PT Bio Farma, PT Sinkona Indonesia lestar, and Vital Laboratories Pvt. Ltd. among others.

What will the Quinidine Sulfate Market Size be During the Forecast Period?

Quinidine Sulfate Market Size

Download Report Sample to Unlock the Quinidine Sulfate Market Size for the Forecast Period and Other Important Statistics

 

Quinidine Sulfate Market: Key Drivers, Trends, and Challenges

The growing incidence of malaria is notably driving the quinidine sulfate market growth, although factors such as the emergence of insecticide-resistant vectors may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the quinidine sulfate industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Quinidine Sulfate Market Driver

  • The growing incidence of malaria is one of the key drivers supporting the quinidine sulfate market growth.
  • The growing incidence of malaria has increased the need for malaria rapid diagnostic devices, which can provide rapid test results and help in the diagnosis of the disease. 
  • According to WHO's latest world malaria report, there were an estimated 241 million malaria cases and 627,000 malaria deaths worldwide in 2020. This represented about 14 million more cases in 2020 compared with 2019 and 69,000 more deaths.
  • According to a report published by the CDC in 2020, more than 219 million estimated cases of malaria were reported across the world. In addition, in the US, approximately 1,700 cases are diagnosed every year. Thus, to support and provide early diagnosis and treatment, the CDC provides information related to malaria through its CDC Division of Parasitic Diseases and Malaria diagnostic website, which is available 24 hours a day.

Key Quinidine Sulfate Market Trend

  • Strong funding for the eradication of malaria is one of the key quinidine sulfate market trends contributing to the market growth. 
  • The funding for the control of malaria is increasing across the globe day by day as it is a life-threatening disease.
  • The highest prevalence of malaria is in African countries, which is largely due to the poor sanitation levels and the insufficient fund to avail a healthy living. The underdeveloped healthcare infrastructure of these countries further restricts the eradication of malaria.
  • To overcome the economic hurdle, various government and non-government organizations, such as Bill and Melinda Gates Foundation, and the World Bank, are conducting various awareness camps that are supported by strong funding. Such factors are expected to increase the demand for quinidine and, thereby, expected to drive the growth of the market in focus during the forecast period.

Key Quinidine Sulfate Market Challenge

  • The emergence of insecticide-resistant vectors is one of the factors impeding the quinidine sulfate market growth.
  • Malaria is a serious disease caused by a parasite of the Plasmodium species that commonly infects mosquitoes. When Anopheles mosquitoes feed on human blood, they transmit the parasite to their human hosts. Vector control remains one of the central components of malaria control.
  • At present, only pyrethroids are approved for use in insecticide-treated nets, the most important malaria control intervention. However, insecticide resistance has emerged as one of the major challenges faced by the National Malaria Control Program in Africa. 
  • The resistance occurring in non-endemic areas also needs to be monitored because of the risk of vector migration to endemic regions. In the Advanced Molecular Detection (AMD) program carried out by the CDC, there are several genetic markers in Anopheles albimanus mosquitoes that are resistant to pyrethroid. Such an increase in the resistance to insecticides is expected to limit the growth of anti-malarial medicines, including quinidine sulfate, during the forecast period.

This quinidine sulfate market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global quinidine sulfate market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the quinidine sulfate market during the forecast period.

Who are the Major Quinidine Sulfate Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Bennet Pharmaceuticals Ltd.
  • Buchler GmbH
  • Cipla Ltd.
  • Ipca Laboratories Ltd.
  • Lark Laboratories India Ltd.
  • Merck and Co. Inc.
  • Merck KGaA
  • PRISM INDUSTRIES LTD.
  • Teva Pharmaceutical Industries Ltd.
  • VIVAN Life Sciences Pvt. Ltd.
  • Biophore India Pharmaceuticals Pvt. Ltd.
  • Inga Laboratories P. Ltd.
  • Koninklijke DSM NV
  • PMC Group Inc.
  • PT Bio Farma
  • PT Sinkona Indonesia lestar
  • Vital Laboratories Pvt. Ltd.

 

This statistical study of the quinidine sulfate market encompasses successful business strategies deployed by the key vendors. The quinidine sulfate market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • ipca.com - Under the unified segment, the company manufactures active pharmaceutical ingredients (APIs), generics, and branded formulations.
  • ipca.com - The company offers quinidine sulfate products such as qinarsol tablets and injections.

To make the most of the opportunities and recover from post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The quinidine sulfate market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Quinidine Sulfate Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the quinidine sulfate market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Quinidine Sulfate Market?

Quinidine Sulfate Market Share by Geography

For more insights on the market share of various regions Request PDF Sample now!

37% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for the quinidine sulfate market in North America. Market growth in this region will be slower than the growth of the market in Asia.

The increasing funding for the development of anti-malarial medicines will facilitate the quinidine sulfate market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 in 2020, which affected a large population in the region, boosted the demand for modification of anti-malarial drugs, including quinidine sulfate. Hence, the COVID-19 pandemic had a positive impact on the growth of the regional market, and it is expected to grow during the forecast period

What are the Revenue-generating Disease Type Segments in the Quinidine Sulfate Market?

Quinidine Sulfate Market Share

To gain further insights on the market contribution of various segments Request PDF Sample

The quinidine sulfate market share growth in the malaria segment will be significant during the forecast period. Malaria is a life-threatening disease that is caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. Moreover, quinidine sulfate is used alone or with other medications to treat malaria in countries such as India and China where malaria is common. Thus, the rising prevalence of malaria, increase in malaria awareness programs, and initiatives by governments to control and prevent the prevalence of malaria across the globe are expected to increase the demand for quinidine sulfate during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the quinidine sulfate market size and actionable market insights on post-COVID-19 impact on each segment.

 

Quinidine Sulfate Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 6.7%

Market growth 2022-2026

$ 427.29 million

Market structure

Concentrated

YoY growth (%)

5.11

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Bennet Pharmaceuticals Ltd., Buchler GmbH, Cipla Ltd., Ipca Laboratories Ltd., Lark Laboratories India Ltd., Merck and Co. Inc., Merck KGaA, PRISM INDUSTRIES LTD., Teva Pharmaceutical Industries Ltd., VIVAN Life Sciences Pvt. Ltd., Biophore India Pharmaceuticals Pvt. Ltd., Inga Laboratories P. Ltd., Koninklijke DSM NV, PMC Group Inc., PT Bio Farma, PT Sinkona Indonesia lestar, and Vital Laboratories Pvt. Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Quinidine Sulfate Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive quinidine sulfate market growth during the next five years
  • Precise estimation of the quinidine sulfate market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the quinidine sulfate industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of quinidine sulfate market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Disease Type
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Disease Type

    • 5.1 Market segments
      • Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
    • 5.2 Comparison by Disease Type
      • Exhibit 26: Chart on Comparison by Disease Type
      • Exhibit 27: Data Table on Comparison by Disease Type
    • 5.3 Malaria - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Malaria - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Malaria - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Malaria - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Malaria - Year-over-year growth 2021-2026 (%)
    • 5.4 Arrhythmias - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Arrhythmias - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Arrhythmias - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Arrhythmias - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Arrhythmias - Year-over-year growth 2021-2026 (%)
    • 5.5 Market opportunity by Disease Type
      • Exhibit 36: Market opportunity by Disease Type ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 40: Chart on Geographic comparison
      • Exhibit 41: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 China - Market size and forecast 2021-2026
      • Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.10 UK - Market size and forecast 2021-2026
      • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.11 Canada - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 78: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 81: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 82: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 83: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 84: Matrix on vendor position and classification
            • 10.3 Bennet Pharmaceuticals Ltd.
              • Exhibit 85: Bennet Pharmaceuticals Ltd. - Overview
              • Exhibit 86: Bennet Pharmaceuticals Ltd. - Product / Service
              • Exhibit 87: Bennet Pharmaceuticals Ltd. - Key offerings
            • 10.4 Buchler GmbH
              • Exhibit 88: Buchler GmbH - Overview
              • Exhibit 89: Buchler GmbH - Product / Service
              • Exhibit 90: Buchler GmbH - Key offerings
            • 10.5 Cipla Ltd.
              • Exhibit 91: Cipla Ltd. - Overview
              • Exhibit 92: Cipla Ltd. - Business segments
              • Exhibit 93: Cipla Ltd. - Key news
              • Exhibit 94: Cipla Ltd. - Key offerings
              • Exhibit 95: Cipla Ltd. - Segment focus
            • 10.6 Ipca Laboratories Ltd.
              • Exhibit 96: Ipca Laboratories Ltd. - Overview
              • Exhibit 97: Ipca Laboratories Ltd. - Product / Service
              • Exhibit 98: Ipca Laboratories Ltd. - Key offerings
            • 10.7 Lark Laboratories India Ltd.
              • Exhibit 99: Lark Laboratories India Ltd. - Overview
              • Exhibit 100: Lark Laboratories India Ltd. - Product / Service
              • Exhibit 101: Lark Laboratories India Ltd. - Key offerings
            • 10.8 Merck and Co. Inc.
              • Exhibit 102: Merck and Co. Inc. - Overview
              • Exhibit 103: Merck and Co. Inc. - Business segments
              • Exhibit 104: Merck and Co. Inc. - Key news
              • Exhibit 105: Merck and Co. Inc. - Key offerings
              • Exhibit 106: Merck and Co. Inc. - Segment focus
            • 10.9 Merck KGaA
              • Exhibit 107: Merck KGaA - Overview
              • Exhibit 108: Merck KGaA - Business segments
              • Exhibit 109: Merck KGaA - Key news
              • Exhibit 110: Merck KGaA - Key offerings
              • Exhibit 111: Merck KGaA - Segment focus
            • 10.10 PRISM INDUSTRIES LTD.
              • Exhibit 112: PRISM INDUSTRIES LTD. - Overview
              • Exhibit 113: PRISM INDUSTRIES LTD. - Product / Service
              • Exhibit 114: PRISM INDUSTRIES LTD. - Key offerings
            • 10.11 Teva Pharmaceutical Industries Ltd.
              • Exhibit 115: Teva Pharmaceutical Industries Ltd. - Overview
              • Exhibit 116: Teva Pharmaceutical Industries Ltd. - Business segments
              • Exhibit 117: Teva Pharmaceutical Industries Ltd. - Key news
              • Exhibit 118: Teva Pharmaceutical Industries Ltd. - Key offerings
              • Exhibit 119: Teva Pharmaceutical Industries Ltd. - Segment focus
            • 10.12 VIVAN Life Sciences Pvt. Ltd.
              • Exhibit 120: VIVAN Life Sciences Pvt. Ltd. - Overview
              • Exhibit 121: VIVAN Life Sciences Pvt. Ltd. - Product / Service
              • Exhibit 122: VIVAN Life Sciences Pvt. Ltd. - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 123: Inclusions checklist
                • Exhibit 124: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 125: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 126: Research methodology
                • Exhibit 127: Validation techniques employed for market sizing
                • Exhibit 128: Information sources
              • 11.5 List of abbreviations
                • Exhibit 129: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Quinidine Sulfate market growth will increase by $427.29 million during 2022-2026.
              The quinidine sulfate market is expected to grow at a CAGR of 6.7% during 2022-2026.
              Technavio has segmented the quinidine sulfate market by geographic (North America, Europe, Asia, and Rest of World (ROW)).
              Bennet Pharmaceuticals Ltd., Buchler GmbH, Cipla Ltd., Ipca Laboratories Ltd., Lark Laboratories India Ltd., Merck and Co. Inc., Merck KGaA, PRISM INDUSTRIES LTD., Teva Pharmaceutical Industries Ltd., VIVAN Life Sciences Pvt. Ltd., Biophore India Pharmaceuticals Pvt. Ltd., Inga Laboratories P. Ltd., Koninklijke DSM NV, PMC Group Inc., PT Bio Farma, PT Sinkona Indonesia lestar, Vital Laboratories Pvt. Ltd. are a few of the key vendors in the quinidine sulfate market.
              North America will register the highest growth rate of 36.54% among the other regions. Therefore, the quinidine sulfate market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the quinidine sulfate market growth are:
              • Growing incidence of malaria
              • Strong funding for eradication of malaria
              The quinidine sulfate market vendors should focus on grabbing business opportunities from the segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO recognized

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single:

                One user only.
                Quick & easy download option

              • Enterprise:

                Unlimited user access (Within your organization)
                Complimentary Customization Included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>